Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) is a Extracorporeal Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Corporation. The primary component is Citric Acid Monohydrate; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Anhydrous Dextrose.
| Product ID | 57826-455_6ad88922-a8f9-6674-e053-2991aa0a6697 |
| NDC | 57826-455 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D) |
| Generic Name | Citric Acid Monohydrate, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Anhydrous Dextrose |
| Dosage Form | Solution |
| Route of Administration | EXTRACORPOREAL |
| Marketing Start Date | 2013-01-10 |
| Marketing Category | NDA / NDA |
| Application Number | BN000127 |
| Labeler Name | Haemonetics Corporation |
| Substance Name | CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE |
| Active Ingredient Strength | 33 mg/mL; mg/mL; mg/mL; mg/mL |
| Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |